Treatments for Lung Cancer

Links to information about treatments for lung cancer.

Reviewed September 2008

 

Printer friendly page

15 Resources Found
Results 1 to 15 displayed.
Title:   Postoperative radiotherapy for non-small cell lung cancer
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Non-small cell lung cancer is the most common type of lung cancer. If this type of lung cancer has not spread, standard treatment is an operation to remove the tumour. Trials have tried giving post-operative radiotherapy (PORT, x-ray treatment after the...
Date:   Oct 2004
Title:   Lung cancer: treatment
Publisher:   myDr
Description:   The main treatments for lung cancer are surgery, radiotherapy (X-ray treatment) and chemotherapy (drug treatment).
Date:   Jan 2002
Title:   Palliative radiotherapy regimens for non-small cell lung cancer
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   In most developed countries lung cancer is one of the commonest tumours. Only 10 to 20% of patients can have surgery with a chance of cure. For many of the rest it can be beneficial to treat the tumour in the lung with radiotherapy to relieve symptoms s...
Date:   Aug 2006
Title:   Chemotherapy and surgery versus surgery alone in non-small cell lung cancer
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   The results of this systematic review suggest that pre-operative chemotherapy might increase survival in patients with non-small cell lung cancer when compared to surgery alone. However, an individual patient data systematic review and meta-analysis is ...
Date:   Apr 2007
Title:   Radical radiotherapy for stage I/II non-small cell lung cancer in patients not sufficiently fit for or declining surgery (medically inoperable)
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   High dose radiation treatment may improve survival for people with non-small cell lung cancer, but more trials are needed.Non-small cell lung cancer (NSCLC) is the most common type of lung cancer. For early cancers the best treatment is surgery. However...
Date:   Oct 2000
Title:   Cranial irradiation for preventing brain metastases of small cell lung cancer in patients in complete remission
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Small-cell lung cancer accounts for 20-25% of lung cancer. Treatment with chemotherapy and thoracic radiotherapy yields complete response rates of 50-85%. But, due to relapses, only 15% of patients who achieved complete response survived at 3 years sinc...
Date:   Jul 2000
Title:   Chemotherapy for non-small cell lung cancer
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Non-small cell lung cancer is the most common type of lung cancer. The standard treatment for small tumours is surgery (operation to remove the tumour) or surgery and radiotherapy (x-ray treatment). Where the tumour has spread within the chest, standard...
Date:   Dec 1999
Title:   Chemotherapy versus best supportive care for extensive small cell lung cancer
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Small-cell lung cancer accounts for nearly a quarter of all new cases of lung cancer. This cancer is often diagnosed after it has spread to the brain, liver, bone or bone marrow and most patients die in the first year after diagnosis. This review found ...
Date:   Jul 2003
Title:   Surgical sealant for preventing air leaks after pulmonary resections in patients with lung cancer
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Air leaks (air coming out of the remaining lung tissue) after lung removal for lung cancer is a common post-operative complication that prolongs hospital stay. Surgical sealants (glue), synthetic or made from blood products, have been developed to preve...
Date:   Jul 2005
Title:   Elemene for the treatment of lung cancer
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Elemene was reported to be effective in alleviating the pain, decreasing the side effects of chemotherapy and improving the quality of life of lung cancer patients in some studies, but the review authors found that all of the claimed randomised controll...
Date:   Jul 2007
Title:   Palliative endobronchial brachytherapy for non-small cell lung cancer
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Patients with inoperable non-small cell lung cancer (NSCLC) have a poor prognosis and the therapeutic options are limited to controlling their symptoms and maintaining their quality of life. Palliative endobronchial brachytherapy (EBB) is used as a trea...
Date:   Dec 2007
Title:   Second-line chemotherapy for non-small cell lung cancer
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Patients with lung cancer and a good physical condition who have not been cured by a first round of chemotherapy often receive a second round of chemotherapy (second-line). A second round of chemotherapy may not increase the survival chances of these pa...
Date:   Jul 2001
Title:   Platinum versus non-platinum chemotherapy regimens for small cell lung cancer
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Small cell lung cancer (SCLC) is a very aggressive form of cancer due to early metastasis. As a result, chemotherapy forms the mainstay of treatment. This review compared platinum-based chemotherapy regimens and non-platinum-based chemotherapy regimens ...
Date:   Aug 2008
Title:   Concurrent chemoradiotherapy in non-small cell lung cancer
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   The use of concurrent chemotherapy and radiotherapy in locally advanced non-small cell lung cancer may combine the benefits of radiotherapy in terms of local control and those of chemotherapy in reducing the risks of metastatic disease. A review of four...
Date:   Jul 2004
Title:   Second or third additional chemotherapy drug for non-small cell lung cancer in patients with advanced disease
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Randomized trials have demonstrated that adding a drug to a single-agent or to a two-drug regimen increased the tumor response in patients with NSCLC, although its impact on survival remains controversial. Sixty-five trials (13601 patients) were eligibl...
Date:   Aug 2007
Results 1 to 15 displayed.

  • Other Related Topics: